Calidi Biotherapeutics (CLDI) Enterprise Value (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Enterprise Value of -$219000.0 for Q4 2025, up 97.61% year-over-year from -$110825.3 in Q4 2024, and up 97.83% quarter-over-quarter from -$10.1 million in Q3 2025.
Calidi Biotherapeutics (CLDI) Enterprise Value (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Enterprise Value history runs 4 years deep, the most recent figure standing at -$219000.0 for Q4 2025.
- In Q4 2025, Enterprise Value rose 97.61% year-over-year to -$219000.0; the TTM figure through Dec 2025 stood at -$219000.0 (up 97.61% YoY), while the FY2025 annual figure was -$219000.0, up 97.61% from the prior year.
- Enterprise Value for Q4 2025 stood at -$219000.0, up from -$10.1 million in the prior quarter.
- The five-year high for Enterprise Value was $210000.0 in Q2 2025, with the low at -$10.2 million in Q1 2025.
- The 4-year median for Enterprise Value is -$1.4 million (2024), against an average of -$4.1 million.
- Peak annual rise in Enterprise Value reached 125.12% in 2025, while the deepest fall reached 796.06% in 2025.
- Calidi Biotherapeutics' Enterprise Value stood at -$218000.0 in 2022, then sank by 794.04% to -$1.9 million in 2023, then tumbled by 369.83% to -$9.2 million in 2024, then jumped by 97.61% to -$219000.0 in 2025.
- Business Quant data shows CLDI's Enterprise Value at -$219000.0 in Q4 2025, -$10.1 million in Q3 2025, and $210000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 2.12 Bn |
| 10 | Calidi Biotherapeutics | 1.98 Mn | -2.12 Mn | - | -4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.10 Mn |
| Dec 31, 2025 | -219,000.00 |
| Sep 30, 2025 | -10.10 Mn |
| Jun 30, 2025 | 210,000.00 |
| Mar 31, 2025 | -10.24 Mn |
| Dec 31, 2024 | -9.16 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -836,000.00 |
| Mar 31, 2024 | -1.14 Mn |
| Dec 31, 2023 | -1.95 Mn |
| Sep 30, 2023 | -10.15 Mn |
| Dec 31, 2022 | -218,000.00 |